|
Register by August 3rd and Save up to $200! |
|
|
|
|
|
 |
Zili
Li, M.D., Ph.D.,
Director, Clinical Research Operations,
Asia-Pacific, Merck |
 |
Whaijen
Soo, M.D.,
Ph.D., Senior Vice President, Medical Research,
Biogen Idec |
 |
Edmund Tsuei,
Ph.D.,
Regional Head, Pharma Development Operations,
Asia-Pacific-Africa, Roche Products Pty Limited |
 |
Steve
Q. Yang, Ph.D.,
Head of Research, Asia, Pfizer Global Research
& Development |
 |
Hua
Zheng, M.D., Ph.D., Director, Global Regulatory Affairs,
Tibotec, Inc. (J&J) |
 |
Guoxin
Zhu, Ph.D.,
CSO / Head of China Chemistry, Discovery
Chemistry Research & Technology, Eli Lilly
Asia, Inc. |
|
|
| • |
Building
Critical Strategic Partnerships to Accelerate Drug
R&D |
| • |
Conducting
Translational Medicine, Biomarker Validation and
Preclinical Safety Studies |
| • |
Protecting
IP & Understanding Barriers and Trends |
| • |
Understanding
the Regulatory Landscape of China |
| • |
Creating
Win-Win Partnerships with Academic Centers |
| • |
Practical
Considerations for Managing Clinical Operations |
|
|
FEATURING PERSPECTIVES, STRATEGIES, & CASE STUDIES FROM:
|
|
|
| • |
Balu Balasubramanian,
Ph.D.,
Director, Discovery Chemistry, Bristol-Myers Squibb Co. |
• |
Eric Meyers,
Vice President, Global Initiatives, Cambridge Healthtech Associates |
| • |
Andrew Branca,
SVP, Strategic Research, Cambridge Healthtech Associates |
• |
Lorenz Ng, M.D.,
CEO, Global Ng Associates, and former Vice President, Research &
Alliances, Asia Pacific, Eli Lilly & Co. |
| • |
Michael Chen,
President, TCM Group, former Associate Director, Biostatistics and
Data Management, Wyeth |
• |
Helen Niu,
M.D., Ph.D.,
Director, Global Development Operations, Asia & Latin America, Amgen,
Inc. |
| • |
Samantha Du,
Ph.D.,
Managing Director, Hutchison MediPharma Ltd. |
• |
Suresh Poosala DVM,
Ph.D.,
Chief of Comparative Medicine and Animal Program Director, NIH |
| • |
Mark Engel,
Chairman, Excel PharmaStudies |
• |
Chris Song,
Manager, Pharmaceutical Segment, Applied Biosystems, former Special Project Manager,
AstraZeneca R&D, China |
| • |
Rajiv Gulati,
Director, China-India Strategy, Corporate Strategic Planning, Eli
Lilly & Co. |
• |
Whaijen
Soo, M.D., Ph.D.,
Senior Vice President, Medical Research, Biogen Idec |
| • |
Ming Guo,
Vice President, Pharmaceutical Science and Manufacturing,
Ascenta Therapeutics, Inc. |
• |
Edmund Tsuei, Ph.D.,
Regional Head, Pharma Development Operations, Asia-Pacific-Africa, Roche Products Pty Limited |
| • |
Matthew Levy,
Director, Protein & Small Molecule Division, Applied Biosystems
- China |
• |
Steve Q. Yang, Ph.D.,
Head of Research, Asia, Pfizer Global Research & Development |
| • |
Zili Li, M.D., Ph.D.,
Director, Clinical Research Operations, Asia-Pacific, Merck |
• |
Hua Zheng, M.D., Ph.D.,
DABT., RAC, Director, Global Regulatory Affairs, Tibotec, Inc. (J&J) |
| • |
Michael N. Liebman,
Ph.D.,
Executive Director, Windber Research Institute |
• |
Guoxin Zhu, Ph.D.,
CSO / Head of China Chemistry, Discovery Chemistry Research & Technology, Eli Lilly Asia, Inc. |
| • |
Mao Mao, M.D.,
Ph.D.,
Associate Director/China Project Liaison, Oncology Clinical Research, Merck |
|
|
|
